ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$19.33 USD
+0.63 (3.37%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $19.32 -0.01 (-0.05%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
ADMA Biologics Inc's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADMA 19.33 +0.63(3.37%)
Will ADMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADMA
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts
ADMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors
Other News for ADMA
ADMA Biologics Shares Cross Above 200 DMA
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 | ADMA Stock News
ADMA Biologics Inc (ADMA) Announces Q2 2025 Financial Results Conference Call | ADMA stock news
Is ADMA Biologics Gaining or Losing Market Support?
Calamos Timpani Small Cap Growth Fund Q1 2025 Commentary